Albumin provides no benefit to hospitalized patients with advanced liver disease

States rapidly expanding vaccine access as supplies surge
3 March 2021
Charity’s pharma investments raise questions around transparency and accountability
3 March 2021

Albumin provides no benefit to hospitalized patients with advanced liver disease

Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver disease, over and above ‘standard care’, finds a large-scale multicentre trial led by UCL researchers.

Comments are closed.